Teijin Pharma Hopes to Derive 50%-Plus of Sales from New Drugs by around 2016: Pres. Uno

New Teijin Pharma Pres. Hiroshi Uno Speaks to Jiho Teijin Pharma aims to raise the proportion of new drugs in its overall ethical drug sales to 50% or more by around 2016 from the current 40% or so, by leveraging...read more